MariMed Announces Participation at Canaccord Genuity’s US Cannabis Symposium on September 30, 2020

Rhea-AI Summary

MariMed Inc. (MRMD) will present at Canaccord Genuity's US Cannabis Symposium on September 30, 2020, at 10:30 a.m. ET, featuring CEO Bob Fireman and CFO John Levine. The company aims to discuss its growth strategy and increasing cannabis revenues during the event. MariMed's management will also hold investor meetings to elaborate on their consolidation and market share expansion initiatives. The company, focused on health and wellness through cannabis products, operates licensed cannabis facilities and develops industry-leading brands, including 'Betty's Eddies™' and 'Nature’s Heritage™'.

Positive

• MariMed is expanding its adult-use consumer market share across the U.S.
• The company aims to launch innovative products, enhancing its portfolio.
• Management will actively engage in investor meetings to discuss growth strategies.

Negative

• None.

Live Presentation at 10:30 am ET on Track 1

NORWOOD, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD:OTCQX) (the “Company” or “MariMed”), a leading multi-state cannabis and hemp operator focused on health and wellness, today announced that the Company’s CEO, Bob Fireman, and CFO, John Levine, will present at Canaccord Genuity’s US Cannabis Symposium on Wednesday, September 30, 2020 at 10:30 a.m. ET on Track 1.

Additionally, MariMed’s management will participate in investor meetings during the conference to discuss the Company’s consolidation strategy and growth trajectory. Investors interested in meeting with management should contact Canaccord representative Nadine Miller at nmiller@cgf.com.

Bob Fireman, Chief Executive Officer of MariMed, said, “MariMed’s growth is accelerating, as we continue to expand our adult-use consumer market share throughout the U.S. and launch innovative new products across our growing number of retail locations. We look forward to sharing some of the reasons behind our increased cannabis revenues and other recent accomplishments, at this leading industry event hosted by Canaccord.”

This one-day event will feature senior management teams representing every facet of the U.S. cannabis industry; including multi-state operators, technology providers, brand owners, hemp producers, oil extractors and ancillary products businesses.

To be added to the email distribution list, please email MRMD@kcsa.com with “MRMD” in the subject.

About MariMed:
MariMed Inc., a multi-state cannabis operator, is dedicated to improving the health and wellness of people through the use of cannabinoids and cannabis products. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. The Company is at the forefront of science and innovation through research developed by its lab technicians and medical advisors resulting in industry-leading products and brands, including "Betty's Eddies™”, “Nature’s Heritage™”, “Bourne Baking Co.", and “Kalm Fusion”. These precision dosed products are focused on specific symptoms and conditions and are licensed and distributed across the country.

For additional information, visit marimedinc.com.

Important Caution Regarding Forward-Looking Statements:
This release contains certain forward-looking statements and information relating to MariMed Inc. that is based on the beliefs of MariMed Inc.'s management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events, including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the law and its enforcement and changes in the economic environment. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "planned, "estimated," "preparing," "potential," "expected," "looks" or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.

All trademarks and service marks are the property of their respective owners.

Company Contact
Jon Levine, CFO
MariMed Inc.
Tel (781) 559-8713

Media Contact
Abigail Diehl
MariMed Inc.
adiehl@marimedinc.com

Annie Graf
KCSA Strategic Communications
agraf@kcsa.com

Investors
KCSA Strategic Communications
Scott Eckstein / Elizabeth Barker
MRMD@kcsa.com

FAQ

When will MariMed present at the US Cannabis Symposium?

MariMed will present at the US Cannabis Symposium on September 30, 2020, at 10:30 a.m. ET.

What topics will MariMed discuss during the US Cannabis Symposium?

MariMed will discuss its growth strategy and increasing cannabis revenues at the symposium.

Who from MariMed will be presenting at the symposium?

CEO Bob Fireman and CFO John Levine will represent MariMed at the symposium.

What is MariMed's focus in the cannabis industry?

MariMed is focused on health and wellness through the development of cannabis and hemp products.